Sarcoidosis;Sarcoïdose

EMC - Pneumologie

Volumn 2, Issue 3, 2005, Pages 147-164

  Valeyre, D ^a,b   Nunes, H ^a,b   Duperron, F ^a,b   Soler, P ^c   Kambouchner, M ^a   Brauner, M ^a  

^a AVICENNE HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c INSERM   (France)

Author keywords

Granuloma; Sarcoidosis

Indexed keywords

EID: 32544455498     PISSN: 17624223     EISSN: 17624223     Source Type: Journal    
DOI: 10.1016/j.emcpn.2005.06.002     Document Type: Short Survey

References (84)

1. Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharma OP, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974;57:847-52.
2. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983;52:525-33.
3. Baughman RP, Lower EE, du Bois R. Sarcoidosis. Lancet 2003;361:1111-8.
4. Rybicki BA, Major M, Popovitch Jr. J, Maliarik MJ, lanuzzi MC. Racial differences in sarcoidosis incidence: a five year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41.
5. Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. Am Rev Respir Dis 1984; 130: 29-32.
6. ATS/ERS/WASOG Committee. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160:736-55.
7. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager Jr. H, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885-9.
8. Lynch JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997;18:755-85.
9. De Remee RA, Andersen HA. Sarcoidosis: a correlation of dyspnea with roentgenographic stage and pulmonary function. Mayo Clin Proc 1974;49:742-5.
10. Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993;6:349-53.
11. Vidal M, Ramama CV, Dusso AS. Stat1 -vitamin D receptor interactions antagonize 1, 25-dihydroxyvitamin D transcriptional activity and enhance stall-mediated transcription. Mol Cell Biol 2002;22:2777-87.
12. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-34.
13. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004;169:696-702.
14. Bergeron A, Bonay M, Kambouchner M, Lecossier D, Riquet M, Soler P, et al. Cytokine patterns in tuberculous and sarcoidosis granulomas. Correlations with histopathologic features of the granulomatous response. J Immunol 1997;159:3034-43.
15. Baughman RP. Therapeutic options for sarcoidosis: new and old. Curr Opin Pulm Med 2002;8:464-9.
16. Valeyre D, Soler P, Tazi A. Sarcoïdose. In: Kahn MF, Peltier AP, Meyer O, Piette JC, editors. Maladies et syndromes systémiques. Paris: Médecine-Sciences Flammarion; 2000. p. 1207-36.
17. Robinson DS, Richeldi L, Saltini C. Granulomatous processes. In: Crystal RG, West JB, editors. The lung. Scientific foundations. New York: Raven Press; 1997. p. 2395-409.
18. Soler P, Basset F, Bernaudin JF, Chrétien J. Morphology and distribution of the cells of a sarcoid granuloma: ultra-structural study of serial sections. Ann N Y Acad Sci 1976; 278:147-60.
19. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;135: 747-60.
20. Soler P, Boussaud V, Moreau J, Bergeron A, Bonnette P, Hance AJ, et al. In situ expression of B7 and CD40 costimulatory molecules by normal human lung macrophages and epithelioid cells in tuberculoid granulomas. Clin Exp Immunol 1999;116:332-9.
21. Ziegenhagen MW, Müller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 2003;253:18-30.
22. Conron M, du Bois RM. Immunological mechanisms in sarcoidosis. Clin Exp Allergy 2001 ;31:543-54.
23. Co DO, Hogan LH, Il-Kim S, Sandor M. T cell contributions to the different phases of granuloma formation. Immunol Lett 2004;92:135-42.
24. duBois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med 2003;253:4-17.
25. Vassilakis DA, Sourvinos G, Markatos M, Psathakis K, Spandidos DA, Siafakas NM, et al. Microsatellite DNA instability and loss of heterozygosity in pulmonary sarcoidosis. Am J Respir Crit Care Med 1999;160:1729-33.
26. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999; 160:1668-72.
27. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis. Environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170:1324-30.
28. James DG, Williams WJ. Kveim-Siltzbach test revisited. Sarcoidosis 1991;8:6-9.
29. Burke WM, Keogh A, Maloney PJ, Delprado W, Bryant DH, Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990;336:1579.
30. Heyll A, Meckenstock G, Aul C, Sohngen D, Borchard F, Hadding U, et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:161-4.
31. Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of japanese and european patients with sarcoidosis. J Clin Microbiol 2002; 40:198-204.
32. Gazouli M, Ikonomopoulos J, Trigidou R, Foteinou M, Kittas C, Gorgoulis V. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 2002;40:3060-3.
33. Hiramatsu J, Katakoa M, Nakata Y, Okazaki K, Tada S, Tanimoto M, et al. Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:197-203.
34. Nishiwaki T, Yoneyama H, Eishi Y, Matsuo N, Tatsumi K, Kimura H, et al. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am JPathol 2004;165: 631-9.
35. Adam-Marchand S. Naccache JM, Monnet I, Kambouchner M, Brauner M, Valeyre D. Ground glass computed tomographic pattern in severe pulmonary beryllium disease. J Comput Assist Tomogr 2003;27:496-500.
36. Takemura T, Matsui Y, Saiki S, Mikami R. Pulmonary vascular involvement in sarcoidosis. Hum Pathol 1992;23:1216-23.
37. Cheung OY, Muhm JR, Helmers RA, Aubry MC, Tazelaar HD, Khoor A, et al. Surgical pathology of granulomatous interstitial pneumonia. Ann Diagn Pathol 2003;7:127-38.
38. Churg A. Pulmonary angiitis and granulomatosis revisited. Hum Pathol 1983;14:868-83.
39. Rybicki BA, lannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001;164:2085-91.
40. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993;148:974-80.
41. Rockoff SD, Rohatgi PK. Unusual manifestation of thoracic sarcoidosis. AJR Am J Roentgenol 1985;144:513-28.
42. Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171:111-6.
43. Grenier P, Valeyre D, Cluzel P, Brauner MW, Lenoir S, Chastang C. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology 1991;179:123-32.
44. Grenier P, Chevret S, Beigelman C, Brauner MW, Chastang C, Valeyre D. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT with Bayesian analysis. Radiolosy 1994;191:383-90.
45. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000;174:1751-7.
46. Brauner MW, Lenoir S, Grenier P, Cluzel P, Battesti JP, Valeyre D. Pulmonary sarcoidosis: CT assessment of lesion reversibility. Radiology 1992;182:349-54.
47. Murdoch J, Müller NL Pulmonary sarcoidosis: changes on follow-up CT examination. AJR Am J Roentgenol 1992;159: 473-7.
48. Wollschlager C, Khan F. Aspergillomas complicating sarcoidosis. A prospective study in 100 patients. Chest 1984;86: 585-8.
49. Lavergne F, Clerici C, Sadoun D, Brauner M, Battesti JP, Valeyre D. Airway obstruction in bronchial sarcoidosis: outcome with treatment. Chest 1999;116:1194-9.
50. Gleeson FV, Traill ZC, Hansell DM. Evidence of expiratory CT scans of small-airway obstruction in sarcoidosis. AJR Am J Roentgenol 1996;166:1052-4.
51. Lenique F, Brauner MW, Grenier P, Battesti JP, Loiseau A, Valeyre D. CT assessment of bronchi in sarcoidosis: endoscopic and pathologic correlations. Radiology 1995;194: 419-23.
52. Damuth TE, Bower JS, Cho K, Dantzker DR. Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest 1980;78:888-91.
53. Hoffstein V, Ranganathan N, Müllen JB. Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis 1986;134:809-11.
54. Lamberto C, Nunes H, Le Toumelin P, Duperron F, Valeyre D, Clerici C. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Chest 2004; 125:2061-8.
55. Levinson RS, Metzger LF, Stanley NN, Kelsen SG, Altose MD, Cherniack NS, et al. Airway function in sarcoidosis. Am J Med 1977;62:51-9.
56. Hadfield JW, Page RL, Flower CDR, Stark JE. Localised airway narrowing in sarcoidosis. Thorax 1982;37:443-7.
57. Costabel U. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992;9(suppl1):211-4.
58. Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 1987;59:896-900.
59. Spickett GP, Farrant J, North ME, Zhang JG, Morgan L, Webster DB. Common variable immunodeficiency: how many diseases. Immunol Today 1997;18:325-8.
60. Sharma OP. Airway obstruction in sarcoidosis. Chest 1978; 73:6-7.
61. Rizzato G, Pezzano A, Sala G, Merlini R, Ladelli L, Tansini G, et al. Right heart impairment in sarcoidosis: haemodynamic ad echocardiographic study. Fur J Respir Dis 1983;64:121-8.
62. Davies J, Nellen M, Goodwin JF. Reversible pulmonary hypertension in sarcoidosis. Postgrad Med J 1982;58: 282-5.
63. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis. JAMA 2002;287:1301-7.
64. Gibson GJ, Prescott RJ, Muers MF, Middleton WG, Mitchell DN, Connolly CK, et al. British Thoracic Society Sarcoidosis study: effects of long-term corticosteroid treatment. Thorax 1996;51:238-47.
65. Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol 1990;23:487-9.
66. Baltzan M, Mehta S, Kirkham TH, Cosio MG. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999;160: 192-7.
67. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999;54:742-6.
68. Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990;299:153-7.
69. Baughman RP, Lower EE. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995;155:846-51.
70. Muller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 1999;14: 1117-22.
71. Lewis SJ, Ainslie GM, Bateman ED, Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:87-92.
72. Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 2003; 124:2023-6.
73. Kouba DJ, Mimouni D, Rencic A, Nousari HC. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol 2003; 148:147-8.
74. Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbe C, Morel P, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol 2004;50:235-41.
75. Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Thalidomide for chronic sarcoidosis. Chest 2002; 122:227-32.
76. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001 ; 18:70-4.
77. Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001; 135:27-31.
78. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, VukPavlovic Z, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 2003; 124: 177-85.
79. Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 1997; 155:1665-9.
80. Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 2001 ; 137:69-73.
81. Barbers RG. Role of transplantation (lung, liver, and heart) in sarcoidosis. Clin Chest Med 1997;18:865-74.
82. Valeyre D, Soler P, Tazi A, Brauner M, Chapelon-Abric C, Sadoun D, etal. Sarcoïdose. In: Kahn MF, Peltier AP, Meyer O, Piette JC, editors. Maladies et syndromes systémiques. Paris: Flammarion Médecine-Sciences; 2000. p. 1207-36.
83. Valeyre D, Soler P, Nunes H, Chambellan A, Brauner M. Sarcoïdose. In: Godeau P, Herson S, Piette JC, editors. Traité de Médecine. Paris: Flammarion Médecine-Sciences; 2004. p. 219-28.
84. Brauner MW, Valeyre D, Grenier P. Sarcoïdose mé diastinopulmonaire. Encycl Méd Chir (Elsevier, Paris), Radiodiagnostic-Cæur-Poumon, 32-464-A-10, 1998, 8 p.